Q1 2026 Holdings
Filed 2026-05-15 | 54 holdings | $759.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Harrow Inc(HROW) | COM | 415858109 | $99.9M | 2,832,230 | 13.2% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $88.8M | 2,545,000 | 11.7% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $70.6M | 2,860,000 | 9.3% |
| Sol-Gel Technologies LTD(SLGL) | SHS NEW | M8694L137 | $39.6M | 500,000 | 5.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $35.3M | 123,000 | 4.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $32.8M | 390,000 | 4.3% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $26.9M | 421,000 | 3.5% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $25.7M | 1,430,000 | 3.4% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $24.1M | 1,312,615 | 3.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $22.8M | 700,000 | 3.0% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $19.5M | 4,675,000 | 2.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $19.2M | 6,300,000 | 2.5% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $18.4M | 2,123,259 | 2.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $17.8M | 535,000 | 2.3% |
| Sanuwave Health Inc(SNWV) | COM | 80303D305 | $17.0M | 981,267 | 2.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $15.8M | 500,000 | 2.1% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $14.1M | 2,561,950 | 1.9% |
| Annexon Inc(ANNX) | COM | 03589W102 | $12.9M | 2,331,761 | 1.7% |
| Alumis Inc(ALMS) | COM | 022307102 | $12.1M | 550,000 | 1.6% |
| Codexis Inc(CDXS) | COM | 192005106 | $11.1M | 6,785,000 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $10.5M | 100,000 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $9.7M | 100,000 | 1.3% |
| Xoma Royalty Corporation(XOMA) | COM NEW | 98419J206 | $9.4M | 300,000 | 1.2% |
| Q32 BIO Inc(QTTB) | COM | 746964105 | $8.1M | 1,256,228 | 1.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $7.8M | 260,000 | 1.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $6.5M | 935,000 | 0.9% |
| CG Oncology Inc(CGON) | COM | 156944100 | $6.4M | 94,800 | 0.8% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $6.0M | 427,608 | 0.8% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.1M | 600,000 | 0.7% |
| Assertio Holdings Inc(ASRT) | COM NEW | 04546C304 | $5.1M | 265,707 | 0.7% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $4.8M | 1,926,997 | 0.6% |
| Sutro Biopharma Inc(STRO) | COM SHS | 869367201 | $4.7M | 190,671 | 0.6% |
| Journey MED Corp(DERM) | COM | 48115J109 | $4.5M | 960,000 | 0.6% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $4.4M | 1,150,000 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $4.1M | 345,100 | 0.5% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $3.8M | 123,000 | 0.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $3.7M | 1,380,000 | 0.5% |
| Biodesix Inc(BDSX) | COM | 09075X207 | $3.5M | 238,047 | 0.5% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.4M | 955,000 | 0.5% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $3.3M | 1,412,656 | 0.4% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.1M | 245,000 | 0.4% |
| Fortress Biotech Inc(FBIO) | COM NEW | 34960Q307 | $2.9M | 1,042,000 | 0.4% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $2.3M | 1,120,000 | 0.3% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $1.9M | 70,000 | 0.2% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $1.7M | 322,600 | 0.2% |
| Lyell Immunopharma Inc(LYEL) | COM NEW | 55083R203 | $1.6M | 79,097 | 0.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.6M | 125,000 | 0.2% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $1.5M | 141,181 | 0.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $1.0M | 112,291 | 0.1% |
| Perspective Therapeutics Inc | CALL | 46489V902 | $834.0K | 200,000 | 0.1% |